mhurhangee/patent-ind-claim-en huggingface dataset:
An anti-syphon valve for controlling the flow of fluid therethrough, the anti-syphon valve comprising: a body having an inlet and an outlet , and a valve member retained within the body , wherein the valve member is movable between a first configuration in which the valve member substantially prevents fluid communication between the inlet and the outlet , and a second configuration in which the valve member permits fluid communication between the inlet and the outlet , and characterised in that the valve member is coupled to a flexible membrane that is movable in response to a pressure differential, and wherein the valve member is associated with a stabiliser comprising a flow control member and configured to allow gradual movement of the valve member between the first and second configurations to thereby stabilise movement of the valve member . a body having an inlet and an outlet , and a valve member retained within the body , wherein the valve member is movable between a first configuration in which the valve member substantially prevents fluid communication between the inlet and the outlet , and a second configuration in which the valve member permits fluid communication between the inlet and the outlet , and characterised in that the valve member is coupled to a flexible membrane that is movable in response to a pressure differential, and wherein the valve member is associated with a stabiliser comprising a flow control member and configured to allow gradual movement of the valve member between the first and second configurations to thereby stabilise movement of the valve member .
Reactor assembly for the production of polymers including a fluidized bed reactor comprising a bottom zone , a middle zone and an upper zone , an inlet for the fluidization gas located in the bottom zone , an outlet for the fluidization gas located in the upper zone ; the outlet for the fluidization gas being coupled with the fluidized bed reactor via inlet via a gas circulation line; means for separation of solids from gas being connected to said gas circulation line; wherein the upper , middle , and bottom zones differentiate with respect to their equivalent diameters, the equivalent cross-sectional diameter of the upper zone being strictly monotonically decreasing with respect to the flow direction of the fluidization gas through the fluidized bed reactor; the middle zone having an essentially constant equivalent cross-sectional diameter with respect to the flow direction of the fluidization gas through the fluidized bed reactor; wherein the ratio of the height of the upper zone to the equivalent cross-sectional diameter of the middle zone is within the range of from 0.7 to 1.1; whereby strictly monotonically decreasing equivalent cross-sectional diameter means that the equivalent cross-sectional diameter will decrease with respect to the flow direction of the fluidization gas through the fluidized bed reactor; characterized in that the ratio of the height of the fluidized bed reactor to the equivalent cross-sectional diameter of the middle zone of the fluidized bed reactor is from 2 to 10; and whereby said upper zone is directly connected to said middle zone
Pharmaceutical composition, comprenant an effective amount of a mixture of inactivated Escherichia coli and Enterococcus faecalis and pharmaceutically acceptable excipients and/or vehicles, for use in treatment, supportive treatment or prophylaxis of dermatological diseases, the composition being in a topically applicable form and being intended for external application to the skin.
Self-inking stamp with a housing in which a stamp unit coupled to an actuating part displaceable relative to the housing is mounted, wherein the actuating part comprises a snap-in point for receiving a snap-in hook of a cover of the self-inking stamp , characterized in that a pusher for releasing a snap-in hook snapped in at the snap-in point is arranged on the actuating part .
A configurable air inlet system, comprising: a rotorcraft fuselage having an engine disposed within the fuselage ; a ram air intake disposed in the fuselage and adapted to allow a ram airflow into the fuselage ; a side air intake disposed in a side of the fuselage and adapted to allow side airflow into the fuselage from the side of the rotorcraft fuselage ; an air inlet plenum coupled to the ram air intake and the side air intake , wherein the air inlet plenum directs the ram airflow and the side airflow to the engine ; a door operably coupled to the fuselage , wherein the door is in an open position clearing the side air intake when the airspeed is below a first threshold and is in a closed position closing the side air intake when the airspeed exceeds a second threshold, wherein the second threshold is above the first threshold; and control logic , having a memory, wherein the control logic is adapted to determine whether the airspeed is at or below the first threshold or at or above the second threshold to control the door position. a rotorcraft fuselage having an engine disposed within the fuselage ; a ram air intake disposed in the fuselage and adapted to allow a ram airflow into the fuselage ; a side air intake disposed in a side of the fuselage and adapted to allow side airflow into the fuselage from the side of the rotorcraft fuselage ; an air inlet plenum coupled to the ram air intake and the side air intake , wherein the air inlet plenum directs the ram airflow and the side airflow to the engine ; a door operably coupled to the fuselage , wherein the door is in an open position clearing the side air intake when the airspeed is below a first threshold and is in a closed position closing the side air intake when the airspeed exceeds a second threshold, wherein the second threshold is above the first threshold; and control logic , having a memory, wherein the control logic is adapted to determine whether the airspeed is at or below the first threshold or at or above the second threshold to control the door position.
A composition for use in a method of treating a disease in a subject that is due to a deficiency of a pulmonary surfactant-associated protein, wherein the pulmonary surfactant-associated protein is selected from SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD, wherein said method comprises pulmonary administration of the composition to the subject, said composition comprising: (a) at least one mRNA molecule at least a portion of which encodes the pulmonary surfactant-associated protein; and (b) a transfer vehicle comprising a lipid nanoparticle, wherein the lipid nanoparticle comprises one or more cationic lipids, one or more non-cationic lipids and one or more PEG-modified lipids. (a) at least one mRNA molecule at least a portion of which encodes the pulmonary surfactant-associated protein; and (b) a transfer vehicle comprising a lipid nanoparticle, wherein the lipid nanoparticle comprises one or more cationic lipids, one or more non-cationic lipids and one or more PEG-modified lipids.
A robot system comprising: a robot ; an imaging device configured to capture a movie of operation of the robot ; a control module configured to control the robot so as to perform work in accordance with work contents information preliminarily stored to indicate a series of work contents; a saving module configured to save image information captured by the imaging device during work performance by the robot in association with time information; and a display module configured to display the image information saved by the saving module together with the time information, wherein the saving module saves the image information in association with the work contents information, and the display module displays movie of the image information together with a work content of the series of work contents which is performed in the movie. a robot ; an imaging device configured to capture a movie of operation of the robot ; a control module configured to control the robot so as to perform work in accordance with work contents information preliminarily stored to indicate a series of work contents; a saving module configured to save image information captured by the imaging device during work performance by the robot in association with time information; and a display module configured to display the image information saved by the saving module together with the time information, wherein the saving module saves the image information in association with the work contents information, and the display module displays movie of the image information together with a work content of the series of work contents which is performed in the movie.
A molten aluminium and aluminium fluoride powder adding and mixing system comprising: a powder tank ; a mixing chamber with a varying cross section in a direction of flow of molten aluminium from a drainpipe , a powder inlet , a molten aluminium inlet , an outlet providing a flow path for a mixture of molten aluminium and the aluminium fluoride powder between the mixing chamber and a crucible for molten aluminium with a crucible cover and at least one connector for connection to a vacuum unit, and at least one deflecting portion opposing the molten aluminium inlet ; and a flow path between the powder tank and the powder inlet in the mixing chamber . a powder tank ; a mixing chamber with a varying cross section in a direction of flow of molten aluminium from a drainpipe , a powder inlet , a molten aluminium inlet , an outlet providing a flow path for a mixture of molten aluminium and the aluminium fluoride powder between the mixing chamber and a crucible for molten aluminium with a crucible cover and at least one connector for connection to a vacuum unit, and at least one deflecting portion opposing the molten aluminium inlet ; and a flow path between the powder tank and the powder inlet in the mixing chamber .
A liposome within which RNA encoding an immunogen of interest is encapsulated, wherein the liposome comprises at least one lipid which includes a polyethylene glycol moiety, such that polyethylene glycol is present on the liposome's exterior, wherein the average molecular mass of the polyethylene glycol is between 1kDa and 3kDa; wherein the RNA includes a 5' cap comprising a 7'-methylguanosine, and the first 1, 2 or 3 5' ribonucleotides are methylated at the 2' position of the ribose.
A multimodal polyethylene resin composition which is suitable for producing a molded product, wherein the composition comprises: 20 to 50 wt% of a copolymer (A) of ethylene and an α-olefin having 6 to 20 carbon atoms, having a melt flow index of 1.0 to 2.5 g/10 minutes (21.6 kg, 190 °C); and 50 to 80 wt% of an ethylene homopolymer (B), wherein the polyethylene resin composition has a melt flow index of 0.5 to 4.5 g/10 minutes (2.16 kg, 190 °C), a density of 0.965 g/cm 3 , a flexural modulus of 8,500 to 11,500 kgf/cm 2 which is measured according to ASTM D790, and a strain hardening modulus of 20 MPa or more which is measured using a specimen having a thickness of 1.0 mm according to ISO 18488:2015. 20 to 50 wt% of a copolymer (A) of ethylene and an α-olefin having 6 to 20 carbon atoms, having a melt flow index of 1.0 to 2.5 g/10 minutes (21.6 kg, 190 °C); and 50 to 80 wt% of an ethylene homopolymer (B), wherein the polyethylene resin composition has a melt flow index of 0.5 to 4.5 g/10 minutes (2.16 kg, 190 °C), a density of 0.965 g/cm 3 , a flexural modulus of 8,500 to 11,500 kgf/cm 2 which is measured according to ASTM D790, and a strain hardening modulus of 20 MPa or more which is measured using a specimen having a thickness of 1.0 mm according to ISO 18488:2015.
Container for food to be cooked having at least one preparation space for receiving and treating food to be cooked, characterised in that the preparation space of the container for food to be cooked is defined by at least one wall device , which has at least one inner wall and at least one outer wall , and that at least one hollow space is formed between the inner wall and the outer wall , which contains at least one working medium for latent heat transfer, so that the heat transfer between the walls substantially takes place through vaporisation or condensation heat from the working medium and at least one sensor unit for detecting at least one characteristic value for a pressure in the hollow space is assigned to the hollow space and that the sensor unit is suitable and designed for transmitting the detected value to a control device of a cooking device , so that controlling of the cooking device can take place as a function of the detected pressure and at least one safety valve is assigned to the hollow space .
A chimeric antigen receptor (CAR) comprising: i) an extracellular domain capable of binding to a predetermined antigen; ii) a transmembrane domain; and iii) an intracellular segment comprising a) a truncated cytoplasmic domain of interleukin-2 receptor beta chain corresponding to SEQ ID NO: 5 and b) an intracellular domain of CD3ζ characterized by having an exogenous STAT3 association motif corresponding to YRHQ (SEQ ID NO: 22) at positions 104-107 of SEQ ID NO: 7. i) an extracellular domain capable of binding to a predetermined antigen; ii) a transmembrane domain; and iii) an intracellular segment comprising a) a truncated cytoplasmic domain of interleukin-2 receptor beta chain corresponding to SEQ ID NO: 5 and b) an intracellular domain of CD3ζ characterized by having an exogenous STAT3 association motif corresponding to YRHQ (SEQ ID NO: 22) at positions 104-107 of SEQ ID NO: 7.
A method of wireless communication performed by a user equipment, UE, comprising: receiving a group-specific radio network temporary identifier, RNTI, associated with non-orthogonal multiple access, NOMA; receiving an indication of whether the group-specific RNTI is associated with contention-based NOMA or contention-free NOMA; and selectively using a group-specific multiple access, MA, signature or a UE-specific MA signature for a NOMA transmission based at least in part on the indication, wherein the NOMA transmission is transmitted on a NOMA bandwidth part determined based at least in part on a bandwidth part configuration signaled to the UE. receiving a group-specific radio network temporary identifier, RNTI, associated with non-orthogonal multiple access, NOMA; receiving an indication of whether the group-specific RNTI is associated with contention-based NOMA or contention-free NOMA; and selectively using a group-specific multiple access, MA, signature or a UE-specific MA signature for a NOMA transmission based at least in part on the indication, wherein the NOMA transmission is transmitted on a NOMA bandwidth part determined based at least in part on a bandwidth part configuration signaled to the UE.
A multi-structured tubular element of a reactor for effecting exothermic/endothermic chemical reactions, said element: - having a length from 10 to 1000 times the main dimension of its transversal section, said transversal section being substantially uniform along the whole length of the multi-structured tubular element; and - comprising two or more monolithic thermoconductive bodies extending longitudinally and having the same length as the tubular element, assembled together so that each has a part of the side surface in contact with the side surface of one or more monolithic thermoconductive bodies adjacent thereto, wherein adjacent means that the two or more monolithic thermoconductive bodies are positioned parallel in the direction of length and said two or more monolithic bodies together form a thermally connected honeycomb structure containing a plurality of longitudinal channels, able to contain a granular solid catalyst, extending from one end to the other of said multi-structured tubular element and substantially parallel to each other and to the main axis of the same element and each monolithic body comprises at least a wall that is part of the outer side surface of the multi-structured tubular element and forms from 5 to 80% of said surface. - having a length from 10 to 1000 times the main dimension of its transversal section, said transversal section being substantially uniform along the whole length of the multi-structured tubular element; and - comprising two or more monolithic thermoconductive bodies extending longitudinally and having the same length as the tubular element, assembled together so that each has a part of the side surface in contact with the side surface of one or more monolithic thermoconductive bodies adjacent thereto,
A fan section for a gas turbine engine comprising: a nacelle , a rotor and a plurality of fan blades , said fan blades for delivering air into a bypass duct defined inwardly of the nacelle and for delivering air into a core engine, and guide vanes inward of said nacelle; a surface of said fan section being provided with a removable film material for accumulation of debris, characterised in that : said removable film material includes a plurality of layers of removable material. a nacelle , a rotor and a plurality of fan blades , said fan blades for delivering air into a bypass duct defined inwardly of the nacelle and for delivering air into a core engine, and guide vanes inward of said nacelle; a surface of said fan section being provided with a removable film material for accumulation of debris, characterised in that : said removable film material includes a plurality of layers of removable material.
A pharmaceutical composition comprising a therapeutically effective amount of an interleukin-4 receptor (IL-4R) antagonist for use in a method for treating, preventing or ameliorating a skin infection comprising administering the composition to a subject in need thereof, wherein: - the subject has atopic dermatitis; - the IL-4R antagonist is an antibody or antigen-binding fragment thereof that specifically binds IL-4Rα, wherein the antibody or antigen-binding fragment thereof comprises a heavy chain CDR (HCDR1) having the amino acid sequence of SEQ ID NO: 3, a HCDR2 having the amino acid sequence of SEQ ID NO: 4, a HCDR3 having the amino acid sequence of SEQ ID NO: 5, a light chain CDR (LCDR1) having the amino acid sequence of SEQ ID NO: 6, a LCDR2 having the amino acid sequence of SEQ ID NO: 7, and a LCDR3 having the amino acid sequence of SEQ ID NO: 8; and - the pharmaceutical composition is administered subcutaneously at a dosage of from 75 to 600 mg. - the subject has atopic dermatitis; - the IL-4R antagonist is an antibody or antigen-binding fragment thereof that specifically binds IL-4Rα, wherein the antibody or antigen-binding fragment thereof comprises a heavy chain CDR (HCDR1) having the amino acid sequence of SEQ ID NO: 3, a HCDR2 having the amino acid sequence of SEQ ID NO: 4, a HCDR3 having the amino acid sequence of SEQ ID NO: 5, a light chain CDR (LCDR1) having the amino acid sequence of SEQ ID NO: 6, a LCDR2 having the amino acid sequence of SEQ ID NO: 7, and a LCDR3 having the amino acid sequence of SEQ ID NO: 8; and - the pharmaceutical composition is administered subcutaneously at a dosage of from 75 to 600 mg.
A method of filtering gas in a powder bed fusion apparatus, in which an object is built layer-by-layer by selective solidification of a powder bed, the powder bed fusion apparatus comprising a build chamber for housing the powder bed , a gas circuit for recirculating the gas, including passing the gas over the powder bed within the build chamber , a plurality of filter assemblies in the gas circuit for filtering process emissions from the gas recirculated through the gas circuit, and a valve system operable to regulate a flow of the gas to each one of the filter assemblies , the valve system comprising at least one valve (121a, 122a; 121b, 122b) capable of being maintained in a plurality of positions, wherein in each position the valve (121a, 122a; 121b, 122b) provides a different sized opening for gas flow to at least one of the filter assemblies , the method comprising controlling the valve system to divide the gas flow between a first one of the filter assemblies housing an unused filter element and at least one second one of the filter assemblies housing a used filter element such that less gas flows through the first filter assembly than the or each second filter assembly and, after an initial time period, the flow of the gas to the first and second filter assemblies is altered by increasing the gas flow to the first filter assembly and reducing or stopping the gas flow to the second filter assembly , wherein the initial time period is a period during which powder is solidified using the powder bed fusion apparatus and process emissions are carried away by the gas flow.
A coating composition comprising: a mixture comprising: (a) a polymer prepared from one or more functional monomers comprising a (meth)acrylic monomer, an allyl monomer, or combinations thereof each having an ethylenically unsaturated double bond and an additional reactive functional group; wherein at least some of the additional reactive functional group of the functional monomer remains unreacted during formation of the polymer; and (b) a reactive diluent having a boiling point of greater than 100°C, a viscosity of 1 mPas to 4,000 mPas at 25°C according to ASTM D789 and a reactive functional group that reacts with the reactive functional group on the polymer at a temperature that is lower than the boiling point of the reactive diluent; and a filler material, wherein the coating composition has a measured solids content of at least 96 % based on the total weight of the composition according to test method ASTM D2369. a mixture comprising: (a) a polymer prepared from one or more functional monomers comprising a (meth)acrylic monomer, an allyl monomer, or combinations thereof each having an ethylenically unsaturated double bond and an additional reactive functional group; wherein at least some of the additional reactive functional group of the functional monomer remains unreacted during formation of the polymer; and (b) a reactive diluent having a boiling point of greater than 100°C, a viscosity of 1 mPas to 4,000 mPas at 25°C according to ASTM D789 and a reactive functional group that reacts with the reactive functional group on the polymer at a temperature that is lower than the boiling point of the reactive diluent; and (a) a polymer prepared from one or more functional monomers comprising a (meth)acrylic monomer, an allyl monomer, or combinations thereof each having an ethylenically unsaturated double bond and an additional reactive functional group; wherein at least some of the additional reactive functional group of the functional monomer remains unreacted during formation of the polymer; and (b) a reactive diluent having a boiling point of greater than 100°C, a viscosity of 1 mPas to 4,000 mPas at 25°C according to ASTM D789 and a reactive functional group that reacts with the reactive functional group on the polymer at a temperature that is lower than the boiling point of the reactive diluent; and a filler material,
Extrusion die assembly for an I.S glassware forming machine, comprising a housing , at least two extrusion dies which are arranged movably for performing a shaping process, a drive which is operatively connected to a drive spindle for generating the pressing force to be transmitted to the extrusion dies , and comprising pressing force limiters formed by piston-cylinder units, characterised in that the drive spindle is mounted in the housing so as to be axially non-displaceable and so as to be rotatable about its axis, in that the pressing force limiters are combined in one assembly which is guided vertically and non-rotatably along guide pillars , in that the assembly is connected to a spindle nut housing , which is engaged with the drive spindle , for transmitting only pressing forces, and in that the spindle nut housing is connected to the housing via lateral linear guides , in so doing establishing a transverse force-free operation of the drive spindle .